Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lifecore Biomedical, Inc. (LFCR) following a series of disclosures regarding accounting irregularities and a potential delisting from Nasdaq. The firm encourages investors who suffered losses exceeding $75,000 in Lifecore between October 7, 2020 and March 19, 2024 to contact them for a free consultation.